Skip to main content

Want a detailed portfolio tracker?

Oncolytics Biotech (ONCY) P/E (2025 - 2026)

Oncolytics Biotech (ONCY) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM Oncolytics Biotech (ONCY) P/E is -10.79. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Oncolytics Biotech (ONCY)

YearP/EChange
2026-10.79-31.30%
2025-15.70N/A

Comparison Oncolytics Biotech (ONCY) P/E with competitors

Oncolytics Biotech (ONCY) P/E is -10.79.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.69%
FGENFibroGen Inc0.24-102.22%
CHRSCoherus Biosciences Inc0.85-107.86%
FBIOFortress Biotech Inc0.95-108.80%
ORMPOramed Pharmaceuticals Inc1.50-113.93%
AGENAgenus Inc3.01-127.89%
INVAInnoviva Inc3.15-129.23%
VXRTVaxart Inc3.55-132.90%
CRMDCorMedix Inc3.63-133.63%
CVACCureVac N.V.4.45-141.20%
GLPGGalapagos NV4.86-145.03%
SRPTSarepta Therapeutics Inc4.88-145.25%
ABEOAbeona Therapeutics Inc5.39-149.93%
ABUSArbutus Biopharma Corp5.60-151.86%
ZVRAZevra Therapeutics Inc5.89-154.56%
SPROSpero Therapeutics Inc6.23-157.72%
CGENCompugen Ltd6.31-158.52%
RIGLRigel Pharmaceuticals6.87-163.69%
SLXNSilexion Therapeutics Corp7.30-167.62%
OMEROmeros Corporation9.26-185.81%
AUPHAurinia Pharmaceuticals Inc9.58-188.83%
PLXProtalix BioTherapeutics Inc10.89-200.94%
ACADAcadia Pharmaceuticals Inc11.73-208.70%
TBPHTheravance Biopharma Inc12.26-213.64%
ADMAAdma Biologics Inc12.42-215.09%
HRMYHarmony Biosciences Holdings Inc13.82-228.08%
SABSSAB Biotherapeutics Inc14.14-231.01%
NAGENiagen Bioscience Inc14.82-237.33%
INCYIncyte Corp15.82-246.64%
REGNRegeneron Pharmaceuticals Inc15.86-246.96%
PBYIPuma Biotechnology Inc17.32-260.48%
CPRXCatalyst Pharmaceuticals Inc17.44-261.62%
EXELExelixis Inc17.54-262.54%
TGTXTG Therapeutics Inc18.97-275.77%
MDXGMimedx Group Inc20.55-290.48%
XOMAXOMA Royalty Corp22.87-312.00%
ARGXArgen X SE24.30-325.20%
CTMXCytomX Therapeutics Inc24.82-330.04%
XOMAOXOMA Royalty Corp25.34-334.90%
HALOHalozyme Therapeutics Inc25.62-337.48%
XOMAPXOMA Royalty Corp25.67-337.91%
VRTXVertex Pharmaceuticals Inc27.99-359.46%
RPRXRoyalty Pharma plc - Class A28.69-365.88%
SLNOSoleno Therapeutics Inc29.02-368.92%
ASNDAscendis Pharma A/S30.09-378.84%
LGNDLigand Pharmaceuticals Inc - Class B37.91-451.37%
APLSApellis Pharmaceuticals Inc39.02-461.65%
BMRNBiomarin Pharmaceutical Inc42.21-491.22%
KRYSKrystal Biotech Inc45.34-520.25%
ONCBeiGene Ltd69.54-744.51%
PHARPharming Group N.V.75.03-795.34%
TECHBio-Techne Corp101.96-1044.96%
VCELVericel Corp109.92-1118.76%
ALNYAlnylam Pharmaceuticals Inc117.96-1193.31%
GMABGenmab140.29-1400.23%
TLXTelix Pharmaceuticals Ltd162.15-1602.85%
CORTCorcept Therapeutics Inc212.86-2072.79%